Advertisement

Topics

Latest "French Industry Welcomes Moves Speed Access Innovative Drugs" News Stories

08:07 EST 17th January 2019 | BioPortfolio

Here are the most relevant search results for "French Industry Welcomes Moves Speed Access Innovative Drugs" found in our extensive news archives from over 250 global news sources.

More Information about French Industry Welcomes Moves Speed Access Innovative Drugs on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about French Industry Welcomes Moves Speed Access Innovative Drugs for you to read. Along with our medical data and news we also list French Industry Welcomes Moves Speed Access Innovative Drugs Clinical Trials, which are updated daily. BioPortfolio also has a large database of French Industry Welcomes Moves Speed Access Innovative Drugs Companies for you to search.

Showing "French Industry Welcomes Moves Speed Access Innovative Drugs" News Articles 1–25 of 30,000+

Thursday 17th January 2019

CIO Bulletin Announces DiaCarta Inc. As One of the 30 Fastest Growing Companies of 2018

DiaCarta today announced that CIO Bulletin has named it among the 30 Fastest Growing Companies of 2018. The positioning is based on DiaCarta’s revenue growth, financial status, openness to innovation, global collaboration and partnership, flagship products launching, regulatory progress and ability to forecast future business and technology trends. Selec...


Level Brands Investor Webinar on January 18 to Provide Update on Recent Developments

Level Brands, Inc. (NYSE American: LEVB) (the “Company”), an innovative brand management and licensing company that owns and operates the nationally recognized consumer cannabidiol (CBD) brand cbdMD, will participate in an investor webinar and Q&A session on Friday, January 18, 2019, at 11:00 a.m. EST hosted by RedChip Companies. The ...

Georgia Bio Bolsters Policy Resources Naming Joseph Santoro New VP of Business Development and External Affairs

Georgia Bio, the state’s public policy and business solutions organization representing Georgia’s life sciences sector, today announced an expansion to its team hiring Joseph Santoro as the full-time Vice President of Business Development and External Affairs. This newly created role will provide expanded leadership in developing and implementing sound...


Nerium International Rebrands as “Neora”

Relationship marketer enters new era as anti-aging innovator, leader Nerium International is changing its name to Neora™ as part of a global rebrand that reflects the company’s evolution as a relationship marketer and vision as an anti-aging industry leader. Neora announced the change during its “History in the Making” event on January...

PatientSafe Solutions Welcomes Kathleen Harmon as Chief Clinical Officer

Clinical Communication Industry Veteran to Advance Healthcare Organization’s Mobility Initiatives with an Outcomes-First Approach PatientSafe Solutions, an innovation leader in mobile Clinical Communication & Collaboration (CC&C) solutions, announced today that Kathleen Harmon, MS, RN, CENP has joined the company as Chief Clinical Officer. Br...

Jeremy Edwards Joins SCORR Marketing as Vice President of Strategic Business Development

SCORR Marketing, the leading full-service marketing and communications firm in the health science industry, is pleased to announce the appointment of Jeremy Edwards as vice president of strategic business development. Edwards’ position overseeing business

South Korea Dura Substitute Procedures Outlook to 2025 [Report Updated: 01112018] Prices from USD $2995

South Korea Dura Substitute Procedures Outlook to 2025SummaryGlobalData's new report, South Korea Dura Substitute Procedures Outlook to 2025, provides key procedures data on the South Korea Dura Substitute Procedures. The report provides procedure volumes within market segments Craniotomy Dura Substitutes Procedures and Spinal Dura Substitutes Procedures.The data in the report is derived from dyn...

Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients

Spectrum will receive $160 million in an upfront cash payment and up to $140 million in regulatory and sales-based milestones Staff size will be reduced by approximately 40 percent with the majority of impacted staff transitioning to Acrotech Spectrum will retain a core group of commercial talent to lead the lau...

War on drugs won’t work in Brazil

The market for migraine drugs

Abscess Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Abscess Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Abscess Global Clinical Trials Review, H2, 2018" provides an overview of Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abscess. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The r...

Impact of ACA Medicaid Expansion on Visit Rates for Diabetes

Has Medicaid expansion increased access to preventive care for vulnerable patients? This study assessed changes in preventive care visits and diabetes screening in expansion vs. nonexpansion states. Journal of the American Board of Family Medicine

‘Innovative’ new disease and infection test

Queen’s University researchers have developed a new test to detect disease and infection that could save time, money and possibly lives.

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!

INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks. Affordable, compact and user-friendly, the VIAFLO 96/384 enables straightforward l...

Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-1105 (Dexamethasone Intravitreal Implant)

Phase 2 Clinical Study Initiating Later in First Quarter 2019 Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye today announced that t...

Israeli telehealth co Tyto Care raises $9m

The latest funding recognizes the unique potential of Tyto Care's on-demand, remote telehealth solution to improve healthcare access and delivery in the US, Japan and China.

Bioinspired Nanoscale Drug Delivery Method Developed

NewsWashington State University researchers have developed a novel way to deliver drugs and therapies into cells at the nanoscale without causing toxic effects that have stymied other such efforts.

Proteus Digital Health® Launches Digital Oncology Medicines to Improve Patient Outcomes

Proteus, Fairview Health Services, and University of Minnesota Health are First to Provide Digital Medicines to Cancer Patients Proteus Digital Health®, Inc.,

Synairgen’s LOXL2 fibrosis drugs ready for phase II trials

With the receipt of long-term toxicity results, Synairgen and Pharmaxis now have all the data they need to take to potential partners

Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China

This is the first time that a multinational pharmaceutical company has gained exclusive authorization in China to promote an innovative drug independently developed by a Chinese pharmaceutical company. The post Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China appeared first on Pharmaceutical Business review.

Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer

Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly targeted, oral, small-molecule drugs to treat NASH and cancer, announced today the appointment of Erin Quirk, M.D. as Chief Medical Officer (CMO). Dr. Quirk brings more than two decades of clinical medicine and drug development experience, most ...

Clinical Care Options and Practicing Clinicians Exchange Announce Strategic Combination

Clinical Care Options® (CCO) and Practicing Clinicians Exchange (PCE), two premier and award winning medical and healthcare education companies, announced today that they have combined their businesses. The strategic merger was led by equity financing from Renovus Capital Partners (Renovus), a Philadelphia-based investment firm committed to supporting and...

Patient and medical groups blast Trump administration drug pricing proposal in new ad campaign

Several patient organizations, led by the American Cancer Society’s advocacy arm, are criticizing a Trump administration proposal they say would limit access to medicine for patients with cancer, AIDS and…

Opinion: The U.S. should assess the economic value of drugs rather than leave it up to other countries

Evidence-based assessments of the economic value of drugs can help control the escalating cost of drugs. So why doesn't the U.S. do this work and instead relies on other countries…

Emergence of Cancer Drug Resistance and Focus on Rare Diseases Found in 2018 Published Research

Genomenon Releases New Report on Emerging Genomic Variants in 2018 Scientific Research ANN ARBOR, Mich. (PRWEB) January 17, 2019 Genomenon® has released a research report detailing the top emerging genomic variants in 2018. A variant is defined as a DNA mutation; this information is used in Precision Medicine to diagnose and treat disease. The report was compiled using the research data foun...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks